Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

720 ARTÍCULOS , VIENDO DEL 511 AL 525

Development of disease-modifying therapies against Alzheimer's disease

Iwatsubo T.

Psychiatry Clin Neurosci. 2024 Sep;78(9):491-494. doi: 10.1111/pcn.13681. Epub 2024 Jun 6.

Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial

Ornish D, Madison C, Kivipelto M, Kemp C, McCulloch CE, Galasko D, Artz J, Rentz D, Lin J, Norman K, Ornish A, Tranter S, DeLamarter N, Wingers N, Richling C, Kaddurah-Daouk R, Knight R, McDonald D, Patel L, Verdin E, E Tanzi R, Arnold SE.

Alzheimers Res Ther. 2024 Jun 7;16(1):122. doi: 10.1186/s13195-024-01482-z.

Therapeutic Effects of Plant Anthocyanin against Alzheimer's Disease and Modulate Gut Health, Short-Chain Fatty Acids

Bayazid AB, Lim BO.

Nutrients. 2024 May 21;16(11):1554. doi: 10.3390/nu16111554.

Language impairments in Alzheimer´s disease: What changes can be found between mild and moderate stages of the disease?

Ortiz KZ, De Lira JO, Minett TSC, Bertolucci PHF.

Clinics (Sao Paulo). 2024 Jun 19;79:100412. doi: 10.1016/j.clinsp.2024.100412. eCollection 2024.

Emerging Therapeutic Potential of Fluoxetine on Cognitive Decline in Alzheimer's Disease: Systematic Review

Bougea A, Angelopoulou E, Vasilopoulos E, Gourzis P, Papageorgiou S.

Int J Mol Sci. 2024 Jun 13;25(12):6542. doi: 10.3390/ijms25126542.

Clinical Pipelines for Alzheimer's Disease Psychosis and Agitation

Oguma T, Jino K.

Chem Pharm Bull (Tokyo). 2024;72(7):610-617. doi: 10.1248/cpb.c23-00416.

Hypoglycemia and Alzheimer Disease Risk: The Possible Role of Dasiglucagon

Ali NH, Al-Kuraishy HM, Al-Gareeb AI, Hadi NR, Assiri AA, Alrouji M, Welson NN, Alexiou A, Papadakis M, Batiha GE.

Cell Mol Neurobiol. 2024 Jul 8;44(1):55. doi: 10.1007/s10571-024-01489-y.

Acquired Risk Factors that Influence Risk for Dementia and Possibly Alzheimer Disease

Novak E, Tochtrop M, Schlagel D, Fuller W.

S D Med. 2024 Feb;77(2):87-90.

Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting

Sandoval KE, Witt KA.

Pharmacol Rev. 2024 Oct 16;76(6):1291-1325. doi: 10.1124/pharmrev.124.001117.

Longitudinal Trajectories of the Cognitive Function Index in the A4 Study

Amariglio RE, Grill JD, Rentz DM, Marshall GA, Donohue MC, Liu A, Aisen PS, Sperling RA.

J Prev Alzheimers Dis. 2024;11(4):838-845. doi: 10.14283/jpad.2024.125.

Brexpiprazole for Agitation Associated With Dementia Due to Alzheimer's Disease

Lee D, Clark ED, Antonsdottir IM, Porsteinsson AP.

J Am Med Dir Assoc. 2024 Oct;25(10):105173. doi: 10.1016/j.jamda.2024.105173. Epub 2024 Jul 22.

A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce

Okonkwo OC, Rivera Mindt M, Ashford MT, Conti C, Strong J, Raman R, Donohue MC, Nosheny RL, Flenniken D, Miller MJ, Diaz A, Soto AM, Ances BM, Beigi MR, Doraiswamy PM, Duara R, Farlow MR, Grossman HT, Mintzer JE, Reist C, Rogalski EJ, Sabbagh MN, Salloway S, Schneider LS, Shah RC, Petersen RC, Aisen PS, Weiner MW; Alzheimer’s Disease Neuroimaging Initiative.

JAMA Netw Open. 2024 Aug 1;7(8):e2427073. doi: 10.1001/jamanetworkopen.2024.27073.

Blood Pressure, Antihypertensive Use, and Late-Life Alzheimer and Non-Alzheimer Dementia Risk: An Individual Participant Data Meta-Analysis

Lennon MJ, Lipnicki DM, Lam BCP, Crawford JD, Schutte AE, Peters R, Rydberg-Sterner T, Najar J, Skoog I, Riedel-Heller SG, Röhr S, Pabst A, Lobo A, De-la-Cámara C, Lobo E, Lipton RB, Katz MJ, Derby CA, Kim KW, Han JW, Oh DJ, Rolandi E, Davin A, Rossi M, Scarmeas N, Yannakoulia M, Dardiotis T, Hendrie HC, Gao S, Carriere I, Ritchie K, Anstey KJ, Cherbuin N, Xiao S, Yue L, Li W, Guerchet M, Preux PM, Aboyans V, Haan MN, Aiello A, Scazufca M, Sachdev PS; as the Cohort Studies of Memory in an International Consortium (COSMIC) Group.

Neurology. 2024 Sep 10;103(5):e209715. doi: 10.1212/WNL.0000000000209715. Epub 2024 Aug 14.

Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease

Flieger J, Forma A, Flieger W, Flieger M, Gawlik PJ, Dzierżyński E, Maciejewski R, Teresiński G, Baj J.

Int J Mol Sci. 2024 Aug 18;25(16):8982. doi: 10.3390/ijms25168982.

Recent advancement in understanding of Alzheimer's disease: Risk factors, subtypes, and drug targets and potential therapeutics

Prabha S, Sajad M, Hasan GM, Islam A, Imtaiyaz Hassan M, Thakur SC.

Ageing Res Rev. 2024 Nov;101:102476. doi: 10.1016/j.arr.2024.102476. Epub 2024 Aug 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias